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The Staphylococcus aureus binding site for human fi-
bronectin was determined by unique biologic assays 
based upon the specific adherence of the bacterium to 
nasal epithelial cells. Fibronectin treatment of S. aureus 
caused a reduction in adherence tallies on high granular 
and fully keratinized cells compared to controls (p < 
0.05; p < 0.001). Spinous and low granular cells showed 
no significant differences. The cell wall materials N-ace-
tyl-D-glucosamine, N-acetyl muramic acid, and protein 
A were unable to inhibit the coupling of fibronectin to S. 
aureus. Only ribitol teichoic acid had this property. Fur-
thermore, fibronectin could neutralize the adherence-
blocking ability of teichoic acid, which affects keratin-
ized cells. Thus, teichoic acid seems to be a receptor for 
fibronectin. 
The ability of human fibronectin to bind to Staphylococcus 
aureus has been recently reported [1,2]. Fibronectin is a 
200,000-dalton glycoprotein found in the plasma and on the 
surface of connective tissue, basement membranes, and certain 
epithelial cells [3-5]. Studies have suggested that among other 
functions it may serve as a cell receptor in bacterial adherence 
and as an opsonin [3]. The coupling with S. aureus is specific, 
since only trace amounts of fibronectin were found on Myco-
bacterium butyricum and Escherichia coli [1,3]. Furthermore, 
Pseudomonas aeruginosa is also unaffected, for an increase in 
its attachment to buccal cells has been correlated with the loss 
of fibronectin from the cell surface [5]. 
The molecular identity of the binding site on S. au.reus is still 
umesolved, but protein A appears to be the leading candidate 
[2). In this report, we demonstrate through a unique biologic 
assay that teichoic acid is a staphylococcal receptor for fibro-
nectin. 
MATERIALS AND METHODS 
Bacterium. 
S. au.reus sta in 502A was grown 18 h at 37°C in Tryptic soy broth 
( DJFCO). P rior to testing, the culture was centrifuged, and the pellet 
was washed twice and resuspended in 0.067 M phosphate-buffered saline 
(PBS), pH 6.8. The test concentration was about LO" colony-forming 
uni ts/ mi. 
Nasal Cells 
Healthy volunteers not canying S. au.reu.s in the nose obtained their 
own anterior mucosal cells from both nares wi th a wooden spatula 
fashioned from a tongue depressor [6]. T he specimens, each having 
been dispersed in 1 ml of PBS, were pooled and vacuum washed wi th 
30 ml of PBS onto a membrane (10·/lm pore size, Millipore Corp., 
Bedford, Massachusetts ). A vortex mixer dislodged the ce lls in to 1-3 
ml of buffer. 
Manuscrip t received July 26, 1982; accepted for publication Novem-
ber 19, 1982. 
S upported in part by the Community Service Program of Kaiser 
Foundation Hospitals and the Permanente Medical Group. 
Reprint req uests to: Dr. Raza Aly, Department of Dermatology, 
University of California, Sl!n Francisco, California 94143. 
Abbreviations: 
PBS: phosphate-buffered saline 
Adherence Testing 
The standard procedure of testing for adherence has been presented 
in detail [6,7]. In brief, we combined 1-ml suspensions of S. au.reus and 
nasal cells for 90 min of incubation at 37°C. After wash ing una ttached 
bacteria away by vacuum fil tration, the ce ll preparation was afiixed to 
slides for staining with crystal violet. Nasal cells were differentiated by 
layer of origin [6], and the adhering bacteria on each were ta llied. 
Fibron.ecl.in and Staphylococcal W all Component~> 
To de termine the suitability of this adherence system as an assay for 
fibronectin binding, S . aureus and nasa l ce lls were each mixed with 1 
mg of human plasma fibronectin (Lot 81-1271, Collaborative Research 
Corporation, Waltham, Massachusetts) at 37°C for 90 min and then 
washed in PBS. (Reduced fibronectin yielded a sharp single peak after 
5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis.) For 
both preparations, testing for adherence proceeded as usual. A reduc-
tion in adherence by fibronectin-treated S. aureus would indicate the 
presence of the glycoprotein on the bacterium. 
We next examined the ability of fibron ectin to couple wi th the basic 
constituents of the staphylococcal cell wall . Equal volumes of fibronec-
tin (0.5 mg/ ml) were mixed with 1 mg/ ml of protein A (S igma Chemical 
Co., St. Louis, Missouri) , N-acetyl-D-glucosamine, N-acetyl muramic 
acid, or ribi tol te ichoic acid [8) in PBS. After incubation at 37°C for 60 
min, each solu tion was added in parallel to a tube containing a twice-
washed and centrifuged pellet of a l-mll8-hr culture of S . a.ureus . The 
bacterium was then resuspended and incubated for 90 min at 37°C. 
Next, t he prepara tions were centrifuged and washed twice wi th PBS. 
We mixed each suspension of treated staphylococci with nasal ce lls to 
test for adherence and compared the result with that obtai ned using 
untreated bacteria. In this situation, if fibronectin fa iled to combine 
with a tested wall component, it t hen would be free to couple wi th the 
staphylococcus and thereby affect adherence. 
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Our previous studies [6,8) had shown that te ichoic ac id can block 
adherence of S. au.reu.s to nasal cells, and hence it is regarded as a 
staphylococcal adhesin for epi thelial receptors in this system. This 
knowledge permitted another approach for testing the ab ili ty of teichoic 
acid to link wi th fibronectin. We first mixed 2 mg/ ml of teichoic acid 
with 2 mg/ ml of fibronectin for 60 min at 37°C. Washed nasal cells 
were added to the above solu tion for an additional 90 min of incubation, 
a llowing cellular binding of any free teichoic acid. After washing away 
residual fibronectin and te ichoic acid with PBS, the nasa l ce lls were 
incubated with S. au.reu.s for 90 min at 37°C. Contro ls included un· 
treated cells, cells subjected to fibronectin only, and cells suspended 
with teichoic acid only. Basic to the experimental design was that 
teichoic acid, if fibronectin did not bind it, would have been available 
to attach to the nasa l cells and thereby prevent adherence of the 
staphylococcus. 
T o determine whether the other wa ll components could also be 
tested in this manner, we first needed to learn whether any could attach 
to nasal cells. Before adding the staphylococcus in the basic adherence 
system, we mixed 1 mg of N-acetyl muramic acid , N-acetyl-D-glucosa· 
mine, protein A, D-adonitol (ribi to l) , ribose, o1· D-ribose-1-phosphate 
with the nasal cells for 30 min at 37°C. T esting was repeated, and 
protein A was examined an additional time. We furthermore tested, 
with an incubation period of 60 min, the mixed components of ribi to l 
teichoic acid: acetyl glucosamine, ribose-phosphate, and alanine. 
RESULTS 
The binding of fibronectin to the staphylococcus was imme· 
diately apparent when centrifugation of the suspension yielded 
not the expected pellet but rather a film against the cultme 
tube. Microscopic inspection showed that many of the bacteria 
were in aggregates only a little larger than usual, but diplococci 
were also plentiful. As recorded in Fig 1, fibronectin partially 
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FIG 1. The abili ty of hbronectin-bound S . a.ureus to adhere to nasal 
cells from various layers. 
blocked adherence of S. aureus to the keratinized nasal cells. 
The two trials of this experiment produced nearly identical 
results with statistically significant differences between tallies 
on high-layer granula1· cells and fully keratinized cells (p < 
0.005; p < 0.001). Younger cells were unaffected. This variation 
elimmates the possibili ty of a detrimental effect of increased 
clustering. We noted no change in adherence counts with the 
combination of untreated cocci and fibronect in-treated nasal 
cells. 
The pretreatment of fibron ectin in this system with individ-
ual staphylococcal wall components produced the data of Table 
L Acetyl glucosamine, acetyl muramic acid, and protein A were 
unable to prevent the binding of fibronectin to S. aureus. Only 
teichoic acid could couple with fibron ectin and thus permit the 
unaltered bacterium to attach to the fully keratinized nasal 
cells at normal levels. Any presence of antiteichoic acid or other 
antibodies in the fibronectin preparation, which could confuse 
the results, was likely to exist only at trace levels. 
The involvement of keratinized cells resembled om previous 
tests of staphylococcal teichoic acid as a n ad hesin to cell recep-
tors [6], where prior incubation of nasal cells with the wall 
material prevented the attachment of subsequently added S. 
aureus. We adapted th is assay to confirm t he union of fibro -
nectin and teichoic acid. Table II displays the results of one 
typical trial. The adherence scores of the test preparation were 
essentially the same as normal and fibronectin controls. L ike 
a n anti-antibody, fibronectin had neutralized ad herence-block-
ing teichoic acid. This procedure could not be used for the other 
cell wall materials, since none could effectively interfere with 
adhe rence by attaching to nasal cells (Table III) . 
DISCUSSION 
The cell wall of S. aureus consists essentially of protein A 
and ribitol teichoic acid on a peptidoglycan frame. By two 
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TABI, E I. Ability of teichoic acid to block the coupling of fibron.ectin 
to S. aureus 
Adherent cocci/ nasal ce ll " 
Fibronectin treatment Fully Low granul ar High granula r keratinized 
Control (untreated 21.2 ± 8.9" 55.3 ± 14.4 115.1 ± 29.6 
cocci) 
Acetyl glucosamine 24 .] ± 12.3 52.2 ± 17.5 70.7 ± 20.9' 
Acetyl muramic 19.2 ± 9.4 56.4 ± 16.4 75.1 ± 22.7' 
acid 
Protein A 20.5 ± 7.5 46.7 ± 16.0 70.0 ± 13.4c 
T eichoic acid 22.7 ± 8.4 60.5 ± 15.3 116.2 ± 21.9 
"S. aureus treated with fibron ectin plus wall component. 
" Mean ± SD of 12-24 cells. 
r p < 0.001 by t-test. 
TABLE II. Failure of fibron ectin-bound teich.oic acid to block 
adherence of S. aw ·eus to nasal cells 
Cell t reatment 
None 
Fibronectin only 
T eichoic acid only 
Fibronectin + teichoic 
acid 
Adherent cocci/ cell type 
Low granul ar 
22.8 ± 8.9" 
30.5 ± 7.8 
18.3 ± 8.6 
28.8 ± 8.8 
High granular 
70.1 ± 21.6 
69.2 ± 14.2 
60.6 ± 12.6 
73.6 ± 11.6 
Fu lly 
ke ratinized 
144 .8 ± 32.1 
144.6 ± 38.6 
100.2 ± 23.91' 
146.0 ± 34 .7 
" Mean ± SD of 12-2 1 ce lls. 
" p < 0.001 by t- test. 
TABLE III. Effect of staphylococcal cell wall compon ents on. S . 
a.ureus adherence to na.sal cells 
P ercent. of control/cell type 
T est agent Fullv Low granular High granular kernlinhed 
Adoni tol 67 107 82 
Ribose 92 94 91 
Ribose-phosphate 97 102 99 
Acetyl-glucosamine 116 86 108 
Protein A 110 98 88 
Ribitol teichoic acid [6] 100 100 62" 
Ribose-phosphate, alanine, 74 85 100 
acetyl glucosamine 
Acetyl-muramic acid 104 89 109 
" p < 0.005 by /- test. 
variations of a unique indirect biologic assay, we have demon-
strated that fib ronectin couples with the teichoic acid. Om data, 
which eliminates acetyl glucosamine, acetyl muramic acid, and 
protein A as fibronectin receptors, confirm the work of Kuusela 
[1]. Her studies involved the inhibition of binding of radiola-
beled fibronectin to S. aureus. However, protein A was impli-
cated recently by Doran and Raynor [2]. Using similarly tagged 
fibronectin and protein A-normal and -deficient strains, they 
found binding quantitatively correlated with the protein A 
content of the staphylococci. Protein A-deficient strains did not 
bind fibronectin. Their inhibi tion studies with protein A pro-
duced only a 50% reduction in coupling, leaving room for 
another wall component of protein A-positive strains. Yet an-
other investigative team, using protein A-deficient and protein 
A-excessive mutants, found no correlation of protein A to 
fibronectin binding*. Further studies are needed to explain and 
untangle the conflicting r esul ts. 
• Wadstrom T, Jonsson P, Switalski LM, Rubin K, Ryden C, Hook 
M, Lindberg M: Decreased binding of fibronec tin to Staphylococcus 
aureus mutants of low virulence (abstr). XIII In ternational Congress 
of Microbiology, Boston, Massachusetts, 1982. 
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Our assays, although less sensitive than the above direct 
chemical tests, are the first to examine te ichoic acid. They also 
present a more in vivo-related picture, since plasma fibronectin 
may serve as a receptor for micro bial colonization and, in the 
instance of macrophages, for host defense [3,9). As we observed, 
fibronectin-coated S. au.reus was still able to adhere to nasal 
cells, a lthough in fewer number on the environmentally impor-
tant, most external, fully keratinized cells. Th is information, 
with the knowledge that the teichoic acid blockage of nasal 
cells produces the same effect, suggests that fibronectin is a 
secondary nasal cell receptor for the S. aureus adhesin teichoic 
acid. However, our preliminary immunofluorescent and proteo-
lytic enzyme studies (unpublished data) could not detect the 
glycoprotein. Perh aps its nonantigenic receptive portion 
[1 ,10,11] or a different surface molecule that acts like fibronectin 
may be found. 
The authors thank Charlene Bayles for her helpful advice. 
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Increased Concentrations of Arachidonic Acid, Prostaglandins E 2, D 2, and 
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The buttock skin of clinically normal human subjects 
was subjected to approximately 2.5 minimal erythema 
doses of ultraviolet A irradiation. Deep red erythema 
developed during irradiation, faded slightly within the 
next few hours, increased to maximum intensity between 
9-15 h, and decreased gradually thereafter although still 
persisting strongly at 48 h. Suction blister exudates were 
obtained at 0, 5, 9, 15, 24, and 48 h after irradiation as 
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Abbreviations: 
AA: arachidonic ac id 
BSTFA: bis-trimethylsilyltrifluoroacetam ide 
GC- MS: gas chromatography- mass spectrometry 
1-IPLC: high-pressure liquid chromatography 
MED: minimal erythema dose 
PG: prostaglandin 
UVA: 315-400 nm 
UVB: 280-3 15 nm 
UVC: 100-280 nm 
well as suction blister exudates from a contralateral 
control site and assayed for arachidonic acid, prosta-
glandins Dz and E2, and the prostacyclin breakdown 
product 6-oxo-prostaglandin F, ., by gas chromatogra-
phy-mass spectrometry, and for histamine by radioen-
zyme assay. Increased concentrations of arachidonic 
acid and prostaglandins Dz, Ez, and 6-oxo-prostaglandin 
F,., were found maximally between 5-9 h after irradia-
tion, preceding the phase of maximal erythema. Eleva-
tions of histamine concentration occurred 9-15 h after 
irradiation, preceding and coinciding with the phase of 
maximal erythema. At 24 h, still at the height of the 
erythemal response, all values had returned to near 
control levels. Hence increased concer.trations of ara-
chidonic acid and its products from the cyclooxygenase 
pathway, and of histamine, accompany the early stages 
up to 24 h. A causal role in production of the erythema 
seems likely for these substances although other media-
tors are almost certainly involved. 
Increased concentrations of arachidonic acid (AA) and pros-
taglandins D~ (PGD2), E 2 (PGE2), F2 .. (PGF2.,), and th e prosta-
cyclin breakdown product 6-oxo-prostaglandin F 1,. (6-oxo-
PGF,.,) have previously been demonstrated by quantitative 
